Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer - Concepedia

Concepedia

Publication | Closed Access

Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer

25

Citations

30

References

2018

Year

Needa Virani, Elangovan Thavathiru, Patrick McKernan, Kathleen N. Moore, Doris M. Benbrook, Roger G. Harrison

MedicineImmunologyTumor ImmunityAnti-ox40 ImmunotherapyMetastatic Ovarian CancerImmune Checkpoint InhibitorTumor TargetingCancer TreatmentOncologyRadiation OncologyOvarian Cancer

References

	Year	Citations

Page 1